NCT06155019View on ClinicalTrials.gov

Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

September 15, 2024

Conditions
HIV Infections
Trial Locations (1)

75013

Pitié-Sapêtrière Hospital, Paris

All Listed Sponsors
lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER

NCT06155019 - Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination | Biotech Hunter | Biotech Hunter